Effect of antipsychotic drugs and selective dopaminergic antagonists on dopamine-induced facilitatory activity in prelimbic cortical pyramidal neurons. An in vitro study
A. Ceci et al., Effect of antipsychotic drugs and selective dopaminergic antagonists on dopamine-induced facilitatory activity in prelimbic cortical pyramidal neurons. An in vitro study, NEUROSCIENC, 93(1), 1999, pp. 107-115
Intracellular recordings were obtained from 119 pyramidal neurons localized
in prelimbic cortex, five in the dorsal cingulate cortex, one in the infra
limbic cortex, one in the border of prelimbic and cingulate cortex and two
in the border of prelimbic and infralimbic cortex. The passive membrane pro
perties of these pyramidal neurons (i.e. resting membrane potential, input
membrane resistance, shape of the tetrodotoxin-sensitive action potentials,
spike frequency adaptation with a prominent postspike afterhyperpolarizati
on, tetrodotoxin-sensitive inward rectification in the depolarizing directi
on and the absence of bursting) suggested that they resembled regular spiki
ng or intrinsically bursting pyramidal neurons. Bath application of dopamin
e (EC50 of 1.8 mu M) produced a reversible facilitatory effect on all 119 p
yramidal neurons localized in the middle layer of the prelimbic cortex. No
consistent change in membrane potential was detected during the application
of dopamine. No effect of dopamine was noted on the nine pyramidal neurons
that were not localized in the prelimbic cortex. The facilitatory effect o
f dopamine in prelimbic cortex was concentration dependently antagonized by
haloperidol, risperidone, quetiapine, clozapine and by the selective D-4 d
opaminergic receptor antagonist L-745,870, but not by the selective D2/D3 d
opaminergic receptor antagonist (-)-sulpiride. (+)-SCH 23390, which is a se
lective D-1/D-5 dopamine receptor antagonist, produced, similarly to dopami
ne, a facilitatory effect per se, and an additive effect when co-administer
ed with dopamine.
These results provide evidence that dopamine has a facilitatory effect spec
ifically on pyramidal neurons localized in the middle layer of prelimbic co
rtex. Antipsychotic drugs and L-745,870 block this effect of dopamine. (C)
1999 IBRO. Published by Elsevier Science Ltd.